Cooperative Carbon Alliances: Defining an Agenda for Global Industrial Decarbonisation

by Shawkat, Aylin, Sartor, Oliver
Published in Wirtschaftsdienst (Hamburg)

Castration-resistant prostate cancer: Adaptive responses in the androgen axis

by Egan, Alison, Dong, Yan, Zhang, Haitao, Qi, Yanfeng, Balk, Steven P, Sartor, Oliver
Published in Cancer treatment reviews

The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP)

by Sweeney, Christopher, Nakabayashi, Mari, Regan, Meredith, Xie, Wanling, Hayes, Julia, Keating, Nancy, Li, Suhui, Philipson, Tomas, Buyse, Marc, Halabi, Susan, Kantoff, Philip, Sartor, A Oliver, Soule, Howard, Mahal, Brandon
Published in JNCI : Journal of the National Cancer Institute

Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy

by Cao, Bo, Qi, Yanfeng, Zhang, Guanyi, Xu, Duo, Zhan, Yang, Alvarez, Xavier, Guo, Zhiyong, Fu, Xueqi, Plymate, Stephen R, Sartor, Oliver, Zhang, Haitao, Dong, Yan
Published in Oncotarget

Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment

by Sridhar, Srikala S, Freedland, Stephen J, Gleave, Martin E, Higano, Celestia, Mulders, Peter, Parker, Chris, Sartor, Oliver, Saad, Fred
Published in European urology

Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer

by Zhang, Wensheng, Dong, Yan, Sartor, Oliver, Zhang, Kun
Published in Cancer informatics

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

by Carson, Kenneth R., Evens, Andrew M., Richey, Elizabeth A., Habermann, Thomas M., Focosi, Daniele, Seymour, John F., Laubach, Jacob, Bawn, Susie D., Gordon, Leo I., Winter, Jane N., Furman, Richard R., Vose, Julie M., Zelenetz, Andrew D., Mamtani, Ronac, Raisch, Dennis W., Dorshimer, Gary W., Rosen, Steven T., Muro, Kenji, Gottardi-Littell, Numa R., Talley, Robert L., Sartor, Oliver, Green, David, Major, Eugene O., Bennett, Charles L.
Published in Blood

Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance

by Zhan, Yang, Zhang, Guanyi, Wang, Xiaojie, Qi, Yanfeng, Bai, Shanshan, Li, Dongying, Ma, Tianfang, Sartor, Oliver, Flemington, Erik K, Zhang, Haitao, Lee, Peng, Dong, Yan
Published in Molecular cancer research

Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA

by Bennett, Charles L, Sartor, Oliver A, Armitage, James O, Kantarjian, Hagop
Published in The lancet oncology

Biomarkers for Programmed Death‐1 Inhibition in Prostate Cancer

by Manogue, Charlotte, Cotogno, Patrick, Ledet, Elisa, Lewis, Brian, Wyatt, Alexander W., Sartor, Oliver
Published in The oncologist (Dayton, Ohio)

Denosumab in bone-metastatic prostate cancer： known effects on skeletal＇related events but unknown effects on quality of life

by Sartor, Oliver
Published in Asian journal of andrology

Editorial: Prostate cancer genomics: Application at different stages of a patient's journey

by Poon, Darren M C, Azad, Arun, Castro, Elena, Kanesvaran, Ravindran, Sartor, Oliver
Published in Frontiers in oncology

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy‐Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

by Bennett, Charles L., Nagai, Sumimasa, Bennett, Andrew C., Hoque, Shamia, Nabhan, Chadi, Schoen, Martin W., Hrushesky, William J., Luminari, Stefano, Ray, Paul, Yarnold, Paul R., Witherspoon, Bart, Riente, Josh, Bobolts, Laura, Brusk, John, Tombleson, Rebecca, Knopf, Kevin, Fishman, Marc, Yang, Y. Tony, Carson, Kenneth R., Djulbegovic, Benjamin, Restaino, John, Armitage, James O., Sartor, Oliver A.
Published in The oncologist (Dayton, Ohio)

Androgen deprivation therapy in prostate cancer: new findings and questions for the future

by Sartor, Oliver
Published in The lancet oncology

Androgen receptor variant-7： an important predictive biomarker in castrate resistant prostate cancer

by Sartor, Oliver, Dong, Yan
Published in Asian journal of andrology

PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials

by Ramnaraign, Brian, Sartor, Oliver
Published in The oncologist (Dayton, Ohio)

Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer

by Jang, Albert, Sartor, Oliver, Barata, Pedro C., Paller, Channing J.
Published in Cancers

The current role and limitations of surrogate endpoints in advanced prostate cancer

by Gomella, Leonard G., M.D, Oliver Sartor, A., M.D
Published in Urologic oncology

Independent data monitoring committees: An update and overview

by Sartor, Oliver, M.D, Halabi, Susan, Ph.D
Published in Urologic oncology

Regulatory and clinical considerations for biosimilar oncology drugs

by Bennett, Charles L, Dr, Chen, Brian, PhD, Hermanson, Terhi, MD, Wyatt, Michael D, PhD, Schulz, Richard M, PhD, Georgantopoulos, Peter, MA, Kessler, Samuel, BA, Raisch, Dennis W, PhD, Qureshi, Zaina P, PhD, Lu, Z Kevin, PhD, Love, Bryan L, PharmD, Noxon, Virginia, MS, Bobolts, Laura, PharmD, Armitage, Melissa, PharmD, Bian, John, PhD, Ray, Paul, DO, Ablin, Richard J, PhD, Hrushesky, William J, MD, Macdougall, Iain C, MD, Sartor, Oliver, MD, Armitage, James O, MD
Published in The lancet oncology